阿米替林与口内装置预防偏头痛的随机比较试验

数据集获取（Figshare）

• 源站标题：Amitriptyline and intraoral devices for migraine prevention: a randomized comparative trial
• DOI：10.6084/m9.figshare.6235100.v1
• 发布日期：2018-05-09
• 文件数：4 个
• 文件总体积：825.41 KB
• 源站页面：https://scielo.figshare.com/articles/dataset/Amitriptyline_and_intraoral_devices_for_migraine_prevention_a_randomized_comparative_trial/6235100

命令行下载

curl -L -o "0004-282X-anp-76-04-0213-gf01.jpg" "https://ndownloader.figshare.com/files/11384084"
curl -L -o "0004-282X-anp-76-04-0213-gf02.jpg" "https://ndownloader.figshare.com/files/11384087"
curl -L -o "Table_1.xls" "https://ndownloader.figshare.com/files/11384090"
curl -L -o "Table_2.xls" "https://ndownloader.figshare.com/files/11384093"

文件清单

• 0004-282X-anp-76-04-0213-gf01.jpg（688.62 KB）
• 0004-282X-anp-76-04-0213-gf02.jpg（125.53 KB）
• Table_1.xls（5.63 KB）
• Table_2.xls（5.63 KB）

文件总体积 825.41 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

ABSTRACT Objectives: Nonpharmacological treatments, such as the Nociceptive Trigeminal Inhibition Tension Suppression System (NTI-tss), are approved for migraine prophylaxis. We aimed at evaluating the effectiveness of the NTI-tss and to compare its efficacy with amitriptyline and with a sham intraoral device in the preventive treatment of migraine. Methods: Consecutive patients with migraine were randomized to receive 25 mg of amitriptyline/day (n = 34), NTI-tss (n = 33) and a non-occlusal splint (n = 30). The headache frequency was evaluated at six and 12 weeks. Results: The amitriptyline group showed, respectively, 60% and 64% reduction in attack frequency at six and 12 weeks (P = 0.000). In the NTI-tss and non-occlusal splint groups, reduction was 39% and 30%, respectively, at six weeks and 48% for both groups at 12 weeks. Conclusions: Amitriptyline proved superior to the NTI-tss and the non-occlusal splint. Despite its approval by the United States Food and Drug Administration, the NTI-tss was not superior to a sham device.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.6235100.v1（source: https://scielo.figshare.com/articles/dataset/Amitriptyline_and_intraoral_devices_for_migraine_prevention_a_randomized_comparative_trial/6235100）。